Earnings Feed
Start Free
Home/Filings/4/0001144204-18-002648
4//SEC Filing

WOLF GEOFFREY 4

Accession 0001144204-18-002648

CIK 0001385508other
View on SEC.govCompany Profile

Filed

Jan 17, 7:00 PM ET

Accepted

Jan 18, 3:48 PM ET

Size

29.3 KB

Accession

0001144204-18-002648

Insider Transaction Report

Form 4
Period: 2017-12-14
OPIANT PHARMACEUTICALS, INC.OPNT
WOLF GEOFFREY
Director10% Owner
Transactions
  • Conversion

    Common Stock

    2017-12-19$15.00/sh+37,860$567,900→ 111,497 total
  • Conversion

    Common Stock

    2017-12-14$15.00/sh+20,000$300,000→ 131,497 total
  • Sale

    Common stock

    2017-12-20$22.75/sh−69,016$1,570,114→ 57,850 total
  • Conversion

    Common stock

    2017-12-22$15.00/sh+32,000$480,000→ 178,850 total
  • Sale

    Common Stock

    2017-12-28$22.52/sh−43,000$968,360→ 98,000 total
  • Sale

    Common Stock

    2017-12-21$24.17/sh−20,000$483,400→ 37,850 total
  • Conversion

    Common Stock

    2017-12-21$15.00/sh+109,000$1,635,000→ 146,850 total
  • Conversion

    Common stock

    2017-12-28$15.00/sh+116,150$1,742,250→ 214,150 total
  • Sale

    Common Stock

    2017-12-19$19.69/sh−3,850$75,807→ 127,647 total
  • Sale

    Common Stock

    2017-12-27$21.51/sh−37,850$814,154→ 141,000 total
  • Conversion

    Warrants

    2017-12-19+37,860→ 203,010 total
    Exercise: $15.00From: 2017-09-01Exp: 2017-12-31→ Common Stock (37,860 underlying)
  • Conversion

    Warrants

    2017-12-14+20,000→ 168,160 total
    Exercise: $15.00From: 2017-09-01Exp: 2017-12-31→ Common Stock (20,000 underlying)
  • Conversion

    Warrants

    2017-12-21+109,000→ 148,150 total
    Exercise: $15.00From: 2017-09-01Exp: 2017-12-31→ Common Stock (109,000 underlying)
  • Conversion

    Warrants

    2017-12-22+32,000→ 116,150 total
    Exercise: $15.00From: 2017-09-01Exp: 2017-12-31→ Common Stock (32,000 underlying)
  • Conversion

    Warrants

    2017-12-28+116,150→ 0 total
    Exercise: $15.00From: 2017-09-01Exp: 2017-12-31→ Common Stock (116,150 underlying)
Footnotes (2)
  • [F1]This Form 4 is a late filing reporting the changes in beneficial ownership of the Reporting Person as of January 17, 2018. This Form 4 was required to be filed within two business days of December 14, 2017, the date the Reporting Person acquired shares.
  • [F2]These Warrants could only be exercised between the following dates: (i) the earliest date on which the price per Share has traded at or above US$ 30.00 for at least three (3) trading days out of any ten (10) consecutive trading days; and (ii) the Expiration Date (December 31, 2017). These Warrants became exercisable on September 1, 2017.

Documents

1 file

Issuer

OPIANT PHARMACEUTICALS, INC.

CIK 0001385508

→
Entity typeother

Related Parties

1
  • filerCIK 0001657053

Filing Metadata

Form type
4
Filed
Jan 17, 7:00 PM ET
Accepted
Jan 18, 3:48 PM ET
Size
29.3 KB
View on SEC.gov